The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses.
Chen Y, Sun H, Deng Y, Ma Y, Huang H, Liu Y, Zhang Y, Zhang H, Ye S, E M, Guo H, Wu M, Wu C, Pu X, Chen X, Liang C, Ou Q, Weng H, Wu X, Shao Y, Gu A, Lin T.
Chen Y, et al. Among authors: ye s.
Biomark Res. 2023 Jan 25;11(1):11. doi: 10.1186/s40364-022-00443-8.
Biomark Res. 2023.
PMID: 36694231
Free PMC article.